1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
NexImmune, Inc.

NexImmune, Inc.

NEXI
NexImmune, Inc.US flagOther OTC
0.00
USD
- -
- -
139.00Market Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
13
21
28
53
63
32
+ Selling, General & Admin
5
6
10
16
16
13
+ Research & Development
8
15
18
37
47
19
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-13
-21
-28
-53
-63
-32
- Non-Operating (Income) Loss
- -
- -
2
-2
-1
- -
+ Interest Expense, Net
- -
- -
2
1
-1
-1
+ Interest Expense
- -
- -
2
1
- -
- -
- Interest Income
- -
- -
- -
- -
1
1
+ Other Non-Op (Income) Loss
- -
- -
- -
-3
- -
1
Pretax Income
-13
-21
-30
-51
-63
-32
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-13
-21
-30
-51
-63
-32
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-13
-21
-30
-51
-63
-32
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-13
-21
-30
-51
-63
-32
- Preferred Dividends
2
3
3
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-15
-23
-33
-51
-63
-32
EBIT
-13
-21
-28
-53
-63
-32
EBITDA
-13
-20
-27
-52
-62
-31
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
EBITA
-13
-21
-28
-53
-63
-32
Gross Margin (%)
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
1
1
1
Basic Weighted Avg Shares
- -
1
1
1
1
1
Basic EPS, GAAP
-38.14
-44.88
-41.92
-63.51
-64.95
-30.82
Basic EPS from Cont Ops
-32.84
-39.74
-37.77
-63.04
-64.95
-30.82
Diluted Weighted Avg Shares
- -
1
1
1
1
1
Diluted EPS, GAAP
-38.14
-44.88
-41.92
-63.51
-64.95
-30.82
Diluted EPS from Cont Ops
-32.84
-39.74
-37.77
-63.04
-64.95
-30.82

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
12
11
8
86
37
5
+ Cash, Cash Equivalents & STI
12
10
5
82
35
5
+ Cash & Cash Equivalents
- -
9
5
30
35
3
+ ST Investments
12
1
- -
51
- -
1
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
3
4
3
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
2
3
3
5
6
3
+ Property, Plant & Equip, Net
2
3
3
4
5
1
+ Property, Plant & Equip
2
3
4
7
9
3
- Accumulated Depreciation
- -
1
1
2
3
2
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
2
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
2
Total Assets
14
14
11
91
43
9
+ Payables & Accruals
3
3
5
7
10
5
+ Accounts Payable
1
1
3
1
2
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
2
3
6
7
4
+ ST Debt
- -
- -
19
- -
1
- -
+ ST Borrowings
- -
- -
19
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
1
- -
+ Other ST Liabilities
- -
- -
3
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
3
- -
- -
- -
Total Current Liabilities
3
3
27
7
10
5
+ LT Debt
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
- -
Total Liabilities
3
3
27
7
11
5
+ Preferred Equity and Hybrid Capital
35
54
54
- -
- -
- -
+ Share Capital & APIC
3
5
8
212
223
226
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
3
5
8
211
223
226
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-27
-48
-78
-128
-190
-223
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
11
11
-16
84
32
4
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
11
11
-16
84
32
4
Total Liabilities & Equity
14
14
11
91
43
9
Shares Outstanding
1
1
1
1
1
1
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
1
- -
Net Debt
- -
-9
14
-30
-35
-3
Net Debt to Equity
-3.94
-86.03
-89.41
-36.21
-107.25
-91.25
Tangible Common Equity Ratio
-171.38
-313.52
-613.88
92.01
75.01
40.84
Current Ratio
4.11
3.65
0.31
11.96
3.62
1.06
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-13
-21
-30
-51
-63
-32
+ Depreciation & Amortization
- -
- -
1
1
1
1
+ Non-Cash Items
1
2
3
4
6
5
+ Stock-Based Compensation
1
2
1
6
6
4
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
2
-2
1
1
+ Chg in Non-Cash Work Cap
- -
-1
- -
1
4
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-2
-2
2
2
+ Inc (Dec) in Accts Payable
1
- -
1
3
3
-5
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
-2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-11
-19
-26
-46
-51
-31
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-1
-1
-2
-1
- -
+ Acq of Fixed Prod Assets
-1
-1
-1
-2
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
115
5
- -
+ Increase in Capital Stock
- -
- -
- -
115
5
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
-12
11
1
-51
51
- -
+ Dec in LT Investment
6
18
1
39
73
- -
+ Inc in LT Investment
-18
-7
- -
-90
-22
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-13
9
- -
-54
50
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
22
9
- -
- -
+ Cash From Debt
- -
- -
22
9
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
9
19
- -
1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
9
19
22
125
5
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-15
9
-4
25
4
-31
EBITDA
-13
-20
-27
-52
-62
-31
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
Free Cash Flow
-12
-21
-27
-48
-52
-31
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-5
-8
-93
-52
-31
Free Cash Flow per Basic Share
-30.85
-39.96
-34.49
-59.61
-54.5
-30
Price/Free Cash Flow
- -
- -
- -
-2.14
-0.12
-0.07
Cash Flow to Net Income
0.87
0.94
0.88
0.9
0.82
0.97
Capital Expenditures
-1
-1
-1
-2
-1
- -